Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (81870152, 81901591)
  • Scientific and Technological Developing Plan of Jilin Province (20180101097JC)
  • Jilin Provincial Key Laboratory of Biotherapy (20170622011JC)
  • Fundamental Research Funds for the Central Universities, and the Program for JLU Science and Technology Innovative Research Team (2017TD-08)
  • 13th Five-Year Science and Technology Research of the Education Department of Jilin Province (JJKH20190043KJ)